Spiridow 18mcg Capsules

Spiridow 18mcg Capsules contain the active ingredient Tiotropium, which belongs to a class of medications called anticholinergics. These capsules are used to manage chronic obstructive pulmonary disease (COPD) and asthma by helping to relax the muscles around the airways, making it easier to breathe.

Description:

Spiridow 18mcg Capsules are inhalation capsules containing a fine powder formulation of Tiotropium. The capsules are designed for use with a specific inhalation device, such as a dry powder inhaler (DPI) or a Respimat inhaler.

Uses:

• Chronic Obstructive Pulmonary Disease (COPD): Spiridow 18mcg Capsules are prescribed to improve symptoms of COPD, including shortness of breath, wheezing, and coughing.
• Asthma: These capsules may also be used in asthma management, particularly in patients who require additional bronchodilator therapy.

Side Effects:

Common side effects of Spiridow 18mcg Capsules may include dry mouth, constipation, blurred vision, urinary retention, and urinary tract infections. Some patients may experience worsening of symptoms or paradoxical bronchospasm (sudden narrowing of the airways).

Precautions:

• Spiridow 18mcg Capsules should be used with caution in patients with narrow-angle glaucoma, urinary retention, or prostatic hyperplasia.
• It is important to follow the instructions for use provided with the inhalation device to ensure proper administration of the medication.
• Patients should be advised to avoid getting the powder from the capsules into their eyes, as it may cause irritation.

When Not to Use:

Spiridow 18mcg Capsules are contraindicated in patients with a known hypersensitivity to Tiotropium or any of the other ingredients in the formulation.